Trial intelligence / Profile preview

LEXTOP: Extended Adjuvant Letrozole in Breast Cancer

NCT01072318Phase 4Unknown

Sponsor
Korean Breast Cancer Study Group
Start
Jan 2010
Primary completion
Jan 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of letrozole in breast cancer, sponsored by Korean Breast Cancer Study Group. Status: unknown.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01072318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01072318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call